Moshe Elkabets (Bar Kaufman)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Transcription Factor

Top Venues

NPJ precision oncology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Moshe Elkabets, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC. NPJ precision oncology 8 (1) (2024)
Thomas F Cyberski, Alka Singh, Michael Korzinkin, Vasudha Mishra, Frank W Pun, Le Shen, Claudia Wing, Xiangying Cheng, Brandon Baird, Yuxuan Miao, Moshe Elkabets, Sara E Kochanny, Wenji Guo, Emma Dyer, Alexander T Pearson, Aditya Juloori, Mark Lingen, Grayson Cole, Alex Zhavoronkov, Nishant Agrawal, Evgeny Izumchenko, Ari J Rosenberg
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer. NPJ precision oncology 8 (1) (2024)
Thomas F Cyberski, Alka Singh, Michael Korzinkin, Vasudha Mishra, Frank W Pun, Le Shen, Claudia Wing, Xiangying Cheng, Brandon Baird, Yuxuan Miao, Moshe Elkabets, Sara E Kochanny, Wenji Guo, Emma Dyer, Alexander T Pearson, Aditya Juloori, Mark Lingen, Grayson Cole, Alex Zhavoronkov, Nishant Agrawal, Evgeny Izumchenko, Ari J Rosenberg
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer. NPJ precision oncology 8 (1) (2024)
Moshe Elkabets, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC. NPJ precision oncology 8 (1) (2024)
Moshe Elkabets, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC. NPJ precision oncology 8 (1) (2024)
Thomas F Cyberski, Alka Singh, Michael Korzinkin, Vasudha Mishra, Frank W Pun, Le Shen, Claudia Wing, Xiangying Cheng, Brandon Baird, Yuxuan Miao, Moshe Elkabets, Sara E Kochanny, Wenji Guo, Emma Dyer, Alexander T Pearson, Aditya Juloori, Mark Lingen, Grayson Cole, Alex Zhavoronkov, Nishant Agrawal, Evgeny Izumchenko, Ari J Rosenberg
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer. NPJ precision oncology 8 (1) (2024)
Moshe Elkabets, Orli Abramov, Anna Ievko, Daria Apple, Mark Shlapobersky, Irit Allon, Yariv Greenshpan, Baisali Bhattachrya, Ofir Cohen, Tatiana Charkovsky, Alexandra Gayster, Ruthy Shaco-Levy, Keren Rouvinov, Alejandro Livoff, Moshe Elkabets, Angel Porgador
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer. Science advances 9 (21) (2023)